cancer

NCCN Guidelines for the Prevention and Treatment of Cancer-Related Infections advise clinicians recommend mAbs to ...

AUGUST 5, 2025

A new survey has revealed that three out of four oncologists find the pace of new treatment development ...

JULY 23, 2025

In an ongoing phase 3 trial, rusfertide (Takeda/Protagonist Therapeutics), a first-in-class hepcidin mimetic, ...

JUNE 18, 2025

Pharmacists at the University of North Carolina are increasing access to biomarker-driven cancer treatments via ...

APRIL 10, 2025

Polypharmacy is highly prevalent among adults with cancer and multimorbidity, and is associated with high health ...

MARCH 22, 2025

The bispecific antibody Rybrevant plus Lazcluze significantly extended overall survival in patients with locally ...

MARCH 17, 2025

Voraxaze significantly improves kidney recovery in patients experiencing nephrotoxicity caused by methotrexate, ...

MARCH 16, 2025

Counseling survivors of melanoma on sun protection and skin health is an important role for pharmacists, since ...

MARCH 14, 2025

Early automated follow-up of cancer patients can help pharmacists more efficiently manage side effects of oral ...

JANUARY 28, 2025

Newer cancer therapies—including immune checkpoint inhibitor agents, allogeneic stem cell transplantation and ...

AUGUST 30, 2024

Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence ...

AUGUST 21, 2024

To reduce wastage of injectable cancer drugs, oncology societies support the practice of rounding drug doses to the ...

MAY 24, 2024